澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

DIMERIX LTD

0.475

+0.0051.06%

成交量：69.72万

成交额：32.31万

市值：2.85亿

市盈率：-20.09

高：0.475

开：0.470

低：0.460

收：0.470

52周最高：0.785

52周最低：0.340

股本：6.00亿

流通股本：4.68亿

量比：0.82

换手率：0.15%

股息：- -

股息率：- -

每股收益(TTM):-0.024

每股收益(LYR):-0.024

净资产收益率：-83.97%

总资产收益率：-32.13%

市净率：21.32

市盈率(LYR):-20.09

数据加载中...

总览公司新闻资讯公告

概念

新冠治疗股-1.21%

医药生物股-0.40%

资金流向

资金流入：

资金流出：

新闻资讯

BUZZ-澳大利亚 Dimerix 公司以 48 亿美元出售资产，创下 7 个月新高

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/DXB.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DXB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","market":"AU","secType":"STK","nameCN":"DIMERIX LTD","latestPrice":0.475,"timestamp":1771564320000,"preClose":0.47,"halted":0,"volume":697242,"delay":0,"changeRate":0.010638297872340436,"nameEN":"DIMERIX LTD","floatShares":467696880,"shares":600396776,"eps":-0.023645,"marketStatus":"休市中","change":0.005,"latestTime":"02-20 16:12:00 AEDT","open":0.47,"high":0.475,"low":0.46,"amount":323147,"amplitude":0.031915,"askPrice":0.475,"askSize":13628,"bidPrice":0.47,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":-0.023645,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1771801200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.47,"openAndCloseTimeList":[[1771542000000,1771563600000]],"volumeRatio":0.8178394619535728,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","floatShares":467696880,"roa":"-32.13%","roe":"-83.97%","lyrEps":-0.023645,"volumeRatio":0.8178394619535728,"shares":600396776,"dividePrice":0,"high":0.475,"amplitude":0.031915,"preClose":0.47,"low":0.46,"week52Low":0.34,"pbRate":"21.32","psRate":"51.05","week52High":0.785,"institutionHeld":0,"latestPrice":0.475,"committee":-0.463174,"eps":-0.023645,"divideRate":0,"volume":697242,"delay":0,"ttmEps":-0.023645,"open":0.47,"prevYearClose":0.55,"prevWeekClose":0.475,"prevMonthClose":0.505,"prevQuarterClose":0.55,"fiveDayClose":0.475,"twentyDayClose":0.52,"sixtyDayClose":0.46,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DXB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DXB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DXB.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2593103120","title":"BUZZ-澳大利亚 Dimerix 公司以 48 亿美元出售资产，创下 7 个月新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2593103120","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593103120?lang=zh_cn&edition=fundamental","pubTime":"2025-12-22 12:10","pubTimestamp":1766376617,"startTime":"0","endTime":"0","summary":"12月22日 - ** DimerixDXB.AX股价上涨12.5%至0.63澳元，创七个月来最高水平** 如果涨势得以保持，该股将创下六个月来的最大盘中涨幅** 生物技术公司称美国上市生物技术公司 BioMarin Pharmaceutical BMRN.O将以 48 亿美元收购  公司的美国商业许可合作伙伴 Amicus Therapeutics。** Amicus Therapeutics 是一家生物制药公司，负责向美国市场授权 DXB 的 DMX-200 药物，用于治疗罕见肾病。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nL4S3XS07W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOLD","IE00B7SZLL34.SGD","LU2065171402.SGD","BK7508","DXB.AU","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BMRN","LU2065170008.USD","LU2065169927.USD","BK4139","BK7501","BK7067","IE0002270589.USD","BK4566","LU2065171311.SGD"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/DXB.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"新冠治疗股","bkCode":"BK7501","id":"package_au_concept_xgzlg","changeRate":-0.012067},{"market":"AU","name":"医药生物股","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":-0.00401}]}}